These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 1543546)

  • 1. Lymphocyte proliferation is controlled by both iron availability and regulation of iron uptake pathways.
    Seligman PA; Kovar J; Gelfand EW
    Pathobiology; 1992; 60(1):19-26. PubMed ID: 1543546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroblastoma sensitivity to growth inhibition by deferrioxamine: evidence for a block in G1 phase of the cell cycle.
    Brodie C; Siriwardana G; Lucas J; Schleicher R; Terada N; Szepesi A; Gelfand E; Seligman P
    Cancer Res; 1993 Sep; 53(17):3968-75. PubMed ID: 8358725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of transferrin-indium on cellular proliferation of a human leukemia cell line.
    Moran PL; Seligman PA
    Cancer Res; 1989 Aug; 49(15):4237-41. PubMed ID: 2743310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two saturable mechanisms of iron uptake from transferrin in human melanoma cells: the effect of transferrin concentration, chelators, and metabolic probes on transferrin and iron uptake.
    Richardson DR; Baker E
    J Cell Physiol; 1994 Oct; 161(1):160-8. PubMed ID: 7929602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of agents that inhibit cellular iron incorporation on bladder cancer cell proliferation.
    Seligman PA; Schleicher RB; Siriwardana G; Domenico J; Gelfand EW
    Blood; 1993 Sep; 82(5):1608-17. PubMed ID: 8364209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of non-transferrin-bound and transferring-bound iron uptake in primary hippocampal neurons.
    Ji C; Kosman DJ
    J Neurochem; 2015 Jun; 133(5):668-83. PubMed ID: 25649872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-transferrin dependent 59Fe uptake in phytohemagglutinin-stimulated human peripheral lymphocytes.
    Hamazaki S; Glass J
    Exp Hematol; 1992 May; 20(4):436-41. PubMed ID: 1568461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of cell proliferation on the uptake of transferrin-bound iron by human hepatoma cells.
    Lee AW; Oates PS; Trinder D
    Hepatology; 2003 Oct; 38(4):967-77. PubMed ID: 14512884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that transferrin may function exclusively as an iron donor in promoting lymphocyte proliferation.
    Brock JH; Mainou-Fowler T; Webster LM
    Immunology; 1986 Jan; 57(1):105-10. PubMed ID: 3002966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examination of the antiproliferative activity of iron chelators: multiple cellular targets and the different mechanism of action of triapine compared with desferrioxamine and the potent pyridoxal isonicotinoyl hydrazone analogue 311.
    Chaston TB; Lovejoy DB; Watts RN; Richardson DR
    Clin Cancer Res; 2003 Jan; 9(1):402-14. PubMed ID: 12538494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron and transferrin uptake by phytohemagglutinin-stimulated human peripheral blood lymphocytes.
    Taylor PG; Soyano A; Romano E; Layrisse M
    Microbiol Immunol; 1988; 32(9):949-55. PubMed ID: 3210997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell.
    Richardson D; Ponka P; Baker E
    Cancer Res; 1994 Feb; 54(3):685-9. PubMed ID: 8306330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the transferrin receptor in UMR-106-01 osteoblast-like cells.
    Kasai K; Hori MT; Goodman WG
    Endocrinology; 1990 Mar; 126(3):1742-9. PubMed ID: 2307125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence that transferrin supports cell proliferation by supplying iron for DNA synthesis.
    Laskey J; Webb I; Schulman HM; Ponka P
    Exp Cell Res; 1988 May; 176(1):87-95. PubMed ID: 3371425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of growth of the lymphocyte lines by deferoxamine under various iron-supply conditions.
    Kovár J; Seligman P; Gelfand EW
    Folia Biol (Praha); 1993; 39(1):29-39. PubMed ID: 8348983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transferrin iron uptake is stimulated by ascorbate via an intracellular reductive mechanism.
    Lane DJ; Chikhani S; Richardson V; Richardson DR
    Biochim Biophys Acta; 2013 Jun; 1833(6):1527-41. PubMed ID: 23481043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of uptake of transferrin-bound iron by human hepatoma cells by nontransferrin-bound iron.
    Trinder D; Morgan E
    Hepatology; 1997 Sep; 26(3):691-8. PubMed ID: 9303500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antineoplastic drugs that interfere with iron metabolism in cancer cells.
    Head JF; Wang F; Elliott RL
    Adv Enzyme Regul; 1997; 37():147-69. PubMed ID: 9381969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transferrin synthesis by small cell lung cancer cells acts as an autocrine regulator of cellular proliferation.
    Vostrejs M; Moran PL; Seligman PA
    J Clin Invest; 1988 Jul; 82(1):331-9. PubMed ID: 2839550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Examination of the mechanism of action of nitrogen monoxide on iron uptake from transferrin.
    Watts RN; Richardson DR
    J Lab Clin Med; 2000 Aug; 136(2):149-56. PubMed ID: 10945243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.